Global Biologics and Biosimilars Industry Report 2016
The Global Biologics and Biosimilars Industry Report 2016 is a professional and in-depth study on the current state of the Biologics and Biosimilars industry.
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Biologics and Biosimilars market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Biologics and Biosimilars industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 292 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Biologics and Biosimilars market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Biologics and Biosimilars industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 292 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 INDUSTRY OVERVIEW
1.1 Definition and Specifications of Biologics and Biosimilars
1.1.1 Definition of Biologics and Biosimilars
1.1.2 Specifications of Biologics and Biosimilars
1.2 Classification of Biologics and Biosimilars
1.3 Applications of Biologics and Biosimilars
1.4 Industry Chain Structure of Biologics and Biosimilars
1.5 Industry Overview and Major Regjions Status of Biologics and Biosimilars
1.5.1 Industry Overview of Biologics and Biosimilars
1.5.2 Global Major Regions Status of Biologics and Biosimilars
1.6 Industry Policy Analysis of Biologics and Biosimilars
1.7 Industry News Analysis of Biologics and Biosimilars
2 MANUFACTURING COST STRUCTURE ANALYSIS OF BIOLOGICS AND BIOSIMILARS
2.1 Labor Cost Analysis of Biologics and Biosimilars
2.2 Other Costs Analysis of Biologics and Biosimilars
2.3 Manufacturing Cost Structure Analysis of Biologics and Biosimilars
2.4 Manufacturing Process Analysis of Biologics and Biosimilars
2.5 Global Gross of Biologics and Biosimilars 2011-2016
3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF BIOLOGICS AND BIOSIMILARS
3.1 Revenue and Commercial Production Date of Global Key Manufacturers in 2014
3.2 R&D Status and Technology Source of Global Biologics and Biosimilars Key Manufacturers in 2014
4 PRODUCTION ANALYSIS OF BIOLOGICS BY REGIONS AND TYPES
4.1 Global Production of Biologics by Regions 2011-2016
4.2 Global Production of Biologics by Type 2011-2016
4.3 Global and Major Regions Revenue and Growth Rate of Biologics 2011-2016
4.4 Global and Major Manufacturers Revenue (M USD) of Biologics 2011-2016
5 PRODUCTION ANALYSIS OF BIOSIMILARS BY REGIONS, TYPES
5.1 Global Production of Biosimilars by Regions 2011-2016
5.2 Global and Major Regions Revenue and Growth Rate of Biosimilars 2011-2016
5.3 Global and Major Manufacturers Revenue (M USD) of Biologics 2011-2016
6 CONSUMPTION VALUE ANALYSIS OF BIOLOGICS AND BIOSIMILARS BY REGIONS AND APPLICATIONS
6.1 Global Consumption Value of Biologics by Regions 2011-2016
6.2 Global and Major Regions Consumption Value and Growth Rate of Biologics 2011-2016
6.3 Global Consumption Value of Biosimilars by Regions 2011-2016
6.4 Global and Major Regions Consumption Value and Growth Rate of Biosimilars 2011-2016
6.5 Global Consumption Value of Biologics and Biosimilars by Applications 2011-2016
7 SUPPLY, CONSUMPTION ANALYSIS OF BIOLOGICS AND BIOSIMILARS
7.1 Supply, Consumption and Gap of Biologics 2011-2016
7.2 Supply, Consumption and Gap of Biosimilars 2011-2016
7.3 Global Cost, Revenue of Biologics and Biosimilars 2011-2016
7.4 America Cost, Revenue of Biologics and Biosimilars 2011-2016
7.5 Europe Cost, Revenue of Biologics and Biosimilars 2011-2016
7.6 India Cost, Revenue of Biologics and Biosimilars 2011-2016
7.7 China, Cost, Revenue of Biologics and Biosimilars 2011-2016
8 KEY MANUFACTURERS ANALYSIS OF BIOLOGICS AND BIOSIMILARS INDUSTRY
Biologics
8.1 Roche
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Cost, Gross, and Revenue
8.1.4 Contact Information
8.2 Amgen
8.2.1 Company Profile
8.2.2 Product Picture
8.2.3 Cost, Gross, and Revenue
8.2.4 Contact Information
8.3 AbbVie
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Cost, Gross, and Revenue
8.3.4 Contact Information
8.4 Sanofi-Aventis
8.4.1 Sanofi-Aventis Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Cost, Gross, and Revenue
8.4.4 Contact Information
8.5 Johnson & Johnson
8.5.1 Company Profile
8.5.2 Product Picture
8.5.3 Cost, Gross, and Revenue
8.5.4 Contact Information
8.6 Pfizer
8.6.1 Company Profile
8.6.2 Product Picture
8.6.3 Cost, Gross, and Revenue
8.6.4 Contact Information
8.7 Novo Nordisk
8.7.1 Company Profile
8.7.2 Product Picture
8.7.3 Cost, Gross, and Revenue
8.7.4 Contact Information
8.8 Eli Lilly
8.8.1 Eli Lilly
8.8.2 Product Picture
8.8.3 Cost, Gross, and Revenue
8.8.4 Contact Information
8.9 Novartis
8.9.1 Novartis Company Profile
8.9.2 Product Picture and Specifications
8.9.3 Cost, Gross, and Revenue
8.9.4 Contact Information
8.10 Merck
8.10.1 Merck
8.10.2 Product Picture and Specifications
8.10.3 Cost, Gross, and Revenue
8.10.4 Contact Information
8.11 Sun pharma
8.11.1 Sun pharma Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Cost, Gross, and Revenue
8.11.4 Contact Information
8.12 3sbio
8.12.1 3sbio Company Profile
8.12.2 Product Picture
8.12.3 Cost, Gross, and Revenue
8.12.4 Contact Information
8.13 Changchun High Tech
8.13.1 Changchun High Tech Company Profile
8.13.2 Product Picture
8.13.3 Cost, Gross, and Revenue
8.13.4 Contact Information
8.14 CP Guojian Pharmacy
8.14.1 CP Guojian Pharmacy
7.14.2 Product Picture
8.14.3 Cost, Gross, and Revenue
8.14.4 Contact Information
8.15 Biotech Pharma
8.15.1 Biotech Pharma
8.15.2 Product Picture
8.15.3 Cost, Gross, and Revenue
8.15.4 Contact Information
8.16 Gelgen Biopharma
8.16.1 Gelgen Biopharma
8.16.2 Product Picture
8.16.3 Cost, Gross, and Revenue
8.16.4 Contact Information
8.17 Innovent
8.17.1 Innovent
8.17.2 Product Picture
8.17.3 Cost, Gross, and Revenue
8.17.4 Contact Information
8.18 Tong Hua Dong Bao Group
8.18.1 Company Profile
8.18.2 Product Picture
8.18.3 Cost, Gross, and Revenue
8.18.4 Contact Information
8.19 Ganlee
8.19.1 Company Profile
8.19.2 Product Picture
8.19.3 Cost, Gross, and Revenue
8.19.4 Contact Information
8.20 United Laboratories
8.20.1 United Laboratories Company Profile
8.20.2 Product Picture and Specifications
8.20.3 Cost, Gross, and Revenue
8.20.4 Contact Information
Biosimilar
8.1 SANDOZ (NOVARTIS)
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Cost, Gross, and Revenue
7.1.4 Contact Information
8.2 Teva Pharmaceutical
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 Cost, Gross, and Revenue
8.2.4 Contact Information
8.3 Hospira （Pfizer）
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Cost, Gross, and Revenue
8.3.4 Contact Information
8.4 MYLAN
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Cost, Gross, and Revenue
8.4.4 Contact Information
8.5 Sun pharma
8.5.1 Sun Pharma Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Cost, Gross, and Revenue
8.5.4 Contact Information
8.6 3sbio
8.6.1 3sbio Company Profile
8.6.2 Product Picture
8.6.3 Cost, Gross, and Revenue
8.6.4 Contact Information
8.7 Changchun High Tech
8.7.1 Changchun High Tech Company Profile
8.7.2 Product Picture
8.7.3 Cost, Gross, and Revenue
8.6.4 Contact Information
8.8 CP Guojian Pharmacy
8.8.1 CP Guojian Pharmacy
8.8.2 Product Picture
8.8.3 Cost, Gross, and Revenue
8.8.4 Contact Information
8.9 Biotech Pharma
8.9.1 Biotech Pharma
8.9.2 Product Picture
8.9.3 Cost, Gross, and Revenue
8.9.4 Contact Information
8.10 Gelgen Biopharma
8.10.1 Gelgen Biopharma
8.10.2 Product Picture
8.10.3 Cost, Gross, and Revenue
8.10.4 Contact Information
9 MARKETING TRADER OR DISTRIBUTOR ANALYSIS OF BIOLOGICS AND BIOSIMILARS
9.1 Biologics and Biosimilars Marketing Channels Status
9.2 Traders or Distributors of Biologics and Biosimilars with Contact Information
9.3.1 Supply, Consumption and Gap of Biologics 2011-2016
9.3.2 Supply, Consumption and Gap of Biosimilars 2011-2016
10 INDUSTRY CHAIN SUPPLIERS WITH CONTACT INFORMATION OF BIOLOGICS AND BIOSIMILARS
10.1 Manufacturing Equipment Suppliers of Biologicas and Biosimilars with Contact Information
10.2 Major Suppliers of Biologicas and Biosimilars with Contact Information
10.3 Key Consumers of Biologicas and Biosimilars with Contact Information
10.4 Supply Chain Relationship Analysis of Biologics and Biosimilars
11 DEVELOPMENT TREND OF BIOLOGICS AND BIOSIMILARS INDUSTRY 2016-2021
11.1 Capacity and Production Overview of Biologics and Biosimilars 2016-2021
11.2 Production Market Share Analysis of Biologics and Biosimilars 2016-2021
11.3 Sales Overview of Biologics and Biosimilars 2016-2021
11.4 Supply, Sales, and Gap of Biologics and Biosimilars 2016-2021
11.5 Cost, Revenue and Gross Margin of Biologics and Biosimilars 2016-2021
12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF BIOLOGICS AND BIOSIMILARS
12.1 New Project SWOT Analysis of Biologics and Biosimilars
12.2 New Project Investment Feasibility Analysis of Biologics and Biosimilars
13 CONCLUSION OF THE GLOBAL BIOLOGICS AND BIOSIMILARS INDUSTRY REPORT 2016
1.1 Definition and Specifications of Biologics and Biosimilars
1.1.1 Definition of Biologics and Biosimilars
1.1.2 Specifications of Biologics and Biosimilars
1.2 Classification of Biologics and Biosimilars
1.3 Applications of Biologics and Biosimilars
1.4 Industry Chain Structure of Biologics and Biosimilars
1.5 Industry Overview and Major Regjions Status of Biologics and Biosimilars
1.5.1 Industry Overview of Biologics and Biosimilars
1.5.2 Global Major Regions Status of Biologics and Biosimilars
1.6 Industry Policy Analysis of Biologics and Biosimilars
1.7 Industry News Analysis of Biologics and Biosimilars
2 MANUFACTURING COST STRUCTURE ANALYSIS OF BIOLOGICS AND BIOSIMILARS
2.1 Labor Cost Analysis of Biologics and Biosimilars
2.2 Other Costs Analysis of Biologics and Biosimilars
2.3 Manufacturing Cost Structure Analysis of Biologics and Biosimilars
2.4 Manufacturing Process Analysis of Biologics and Biosimilars
2.5 Global Gross of Biologics and Biosimilars 2011-2016
3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF BIOLOGICS AND BIOSIMILARS
3.1 Revenue and Commercial Production Date of Global Key Manufacturers in 2014
3.2 R&D Status and Technology Source of Global Biologics and Biosimilars Key Manufacturers in 2014
4 PRODUCTION ANALYSIS OF BIOLOGICS BY REGIONS AND TYPES
4.1 Global Production of Biologics by Regions 2011-2016
4.2 Global Production of Biologics by Type 2011-2016
4.3 Global and Major Regions Revenue and Growth Rate of Biologics 2011-2016
4.4 Global and Major Manufacturers Revenue (M USD) of Biologics 2011-2016
5 PRODUCTION ANALYSIS OF BIOSIMILARS BY REGIONS, TYPES
5.1 Global Production of Biosimilars by Regions 2011-2016
5.2 Global and Major Regions Revenue and Growth Rate of Biosimilars 2011-2016
5.3 Global and Major Manufacturers Revenue (M USD) of Biologics 2011-2016
6 CONSUMPTION VALUE ANALYSIS OF BIOLOGICS AND BIOSIMILARS BY REGIONS AND APPLICATIONS
6.1 Global Consumption Value of Biologics by Regions 2011-2016
6.2 Global and Major Regions Consumption Value and Growth Rate of Biologics 2011-2016
6.3 Global Consumption Value of Biosimilars by Regions 2011-2016
6.4 Global and Major Regions Consumption Value and Growth Rate of Biosimilars 2011-2016
6.5 Global Consumption Value of Biologics and Biosimilars by Applications 2011-2016
7 SUPPLY, CONSUMPTION ANALYSIS OF BIOLOGICS AND BIOSIMILARS
7.1 Supply, Consumption and Gap of Biologics 2011-2016
7.2 Supply, Consumption and Gap of Biosimilars 2011-2016
7.3 Global Cost, Revenue of Biologics and Biosimilars 2011-2016
7.4 America Cost, Revenue of Biologics and Biosimilars 2011-2016
7.5 Europe Cost, Revenue of Biologics and Biosimilars 2011-2016
7.6 India Cost, Revenue of Biologics and Biosimilars 2011-2016
7.7 China, Cost, Revenue of Biologics and Biosimilars 2011-2016
8 KEY MANUFACTURERS ANALYSIS OF BIOLOGICS AND BIOSIMILARS INDUSTRY
Biologics
8.1 Roche
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Cost, Gross, and Revenue
8.1.4 Contact Information
8.2 Amgen
8.2.1 Company Profile
8.2.2 Product Picture
8.2.3 Cost, Gross, and Revenue
8.2.4 Contact Information
8.3 AbbVie
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Cost, Gross, and Revenue
8.3.4 Contact Information
8.4 Sanofi-Aventis
8.4.1 Sanofi-Aventis Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Cost, Gross, and Revenue
8.4.4 Contact Information
8.5 Johnson & Johnson
8.5.1 Company Profile
8.5.2 Product Picture
8.5.3 Cost, Gross, and Revenue
8.5.4 Contact Information
8.6 Pfizer
8.6.1 Company Profile
8.6.2 Product Picture
8.6.3 Cost, Gross, and Revenue
8.6.4 Contact Information
8.7 Novo Nordisk
8.7.1 Company Profile
8.7.2 Product Picture
8.7.3 Cost, Gross, and Revenue
8.7.4 Contact Information
8.8 Eli Lilly
8.8.1 Eli Lilly
8.8.2 Product Picture
8.8.3 Cost, Gross, and Revenue
8.8.4 Contact Information
8.9 Novartis
8.9.1 Novartis Company Profile
8.9.2 Product Picture and Specifications
8.9.3 Cost, Gross, and Revenue
8.9.4 Contact Information
8.10 Merck
8.10.1 Merck
8.10.2 Product Picture and Specifications
8.10.3 Cost, Gross, and Revenue
8.10.4 Contact Information
8.11 Sun pharma
8.11.1 Sun pharma Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Cost, Gross, and Revenue
8.11.4 Contact Information
8.12 3sbio
8.12.1 3sbio Company Profile
8.12.2 Product Picture
8.12.3 Cost, Gross, and Revenue
8.12.4 Contact Information
8.13 Changchun High Tech
8.13.1 Changchun High Tech Company Profile
8.13.2 Product Picture
8.13.3 Cost, Gross, and Revenue
8.13.4 Contact Information
8.14 CP Guojian Pharmacy
8.14.1 CP Guojian Pharmacy
7.14.2 Product Picture
8.14.3 Cost, Gross, and Revenue
8.14.4 Contact Information
8.15 Biotech Pharma
8.15.1 Biotech Pharma
8.15.2 Product Picture
8.15.3 Cost, Gross, and Revenue
8.15.4 Contact Information
8.16 Gelgen Biopharma
8.16.1 Gelgen Biopharma
8.16.2 Product Picture
8.16.3 Cost, Gross, and Revenue
8.16.4 Contact Information
8.17 Innovent
8.17.1 Innovent
8.17.2 Product Picture
8.17.3 Cost, Gross, and Revenue
8.17.4 Contact Information
8.18 Tong Hua Dong Bao Group
8.18.1 Company Profile
8.18.2 Product Picture
8.18.3 Cost, Gross, and Revenue
8.18.4 Contact Information
8.19 Ganlee
8.19.1 Company Profile
8.19.2 Product Picture
8.19.3 Cost, Gross, and Revenue
8.19.4 Contact Information
8.20 United Laboratories
8.20.1 United Laboratories Company Profile
8.20.2 Product Picture and Specifications
8.20.3 Cost, Gross, and Revenue
8.20.4 Contact Information
Biosimilar
8.1 SANDOZ (NOVARTIS)
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Cost, Gross, and Revenue
7.1.4 Contact Information
8.2 Teva Pharmaceutical
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 Cost, Gross, and Revenue
8.2.4 Contact Information
8.3 Hospira （Pfizer）
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Cost, Gross, and Revenue
8.3.4 Contact Information
8.4 MYLAN
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Cost, Gross, and Revenue
8.4.4 Contact Information
8.5 Sun pharma
8.5.1 Sun Pharma Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Cost, Gross, and Revenue
8.5.4 Contact Information
8.6 3sbio
8.6.1 3sbio Company Profile
8.6.2 Product Picture
8.6.3 Cost, Gross, and Revenue
8.6.4 Contact Information
8.7 Changchun High Tech
8.7.1 Changchun High Tech Company Profile
8.7.2 Product Picture
8.7.3 Cost, Gross, and Revenue
8.6.4 Contact Information
8.8 CP Guojian Pharmacy
8.8.1 CP Guojian Pharmacy
8.8.2 Product Picture
8.8.3 Cost, Gross, and Revenue
8.8.4 Contact Information
8.9 Biotech Pharma
8.9.1 Biotech Pharma
8.9.2 Product Picture
8.9.3 Cost, Gross, and Revenue
8.9.4 Contact Information
8.10 Gelgen Biopharma
8.10.1 Gelgen Biopharma
8.10.2 Product Picture
8.10.3 Cost, Gross, and Revenue
8.10.4 Contact Information
9 MARKETING TRADER OR DISTRIBUTOR ANALYSIS OF BIOLOGICS AND BIOSIMILARS
9.1 Biologics and Biosimilars Marketing Channels Status
9.2 Traders or Distributors of Biologics and Biosimilars with Contact Information
9.3.1 Supply, Consumption and Gap of Biologics 2011-2016
9.3.2 Supply, Consumption and Gap of Biosimilars 2011-2016
10 INDUSTRY CHAIN SUPPLIERS WITH CONTACT INFORMATION OF BIOLOGICS AND BIOSIMILARS
10.1 Manufacturing Equipment Suppliers of Biologicas and Biosimilars with Contact Information
10.2 Major Suppliers of Biologicas and Biosimilars with Contact Information
10.3 Key Consumers of Biologicas and Biosimilars with Contact Information
10.4 Supply Chain Relationship Analysis of Biologics and Biosimilars
11 DEVELOPMENT TREND OF BIOLOGICS AND BIOSIMILARS INDUSTRY 2016-2021
11.1 Capacity and Production Overview of Biologics and Biosimilars 2016-2021
11.2 Production Market Share Analysis of Biologics and Biosimilars 2016-2021
11.3 Sales Overview of Biologics and Biosimilars 2016-2021
11.4 Supply, Sales, and Gap of Biologics and Biosimilars 2016-2021
11.5 Cost, Revenue and Gross Margin of Biologics and Biosimilars 2016-2021
12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF BIOLOGICS AND BIOSIMILARS
12.1 New Project SWOT Analysis of Biologics and Biosimilars
12.2 New Project Investment Feasibility Analysis of Biologics and Biosimilars
13 CONCLUSION OF THE GLOBAL BIOLOGICS AND BIOSIMILARS INDUSTRY REPORT 2016
TABLES AND FIGURES
Figure Biologics and Biosimilars Product Picture
Figure Biologics and Biosimilars Product Picture
Table Specifications of Biologics and Biosimilars
Table Classification of Biologics and Biosimilars
Figure Global Production Market Share of Biologics and Biosimilars by Type in 2015
Table Application Fields of Biologics and Biosimilars Products
Figure 2014 Global Biologics and Biosimilars Major Applications Sales Share
Figure Industry Chain Structure of Biologics and Biosimilars
Table Industry Policy of Biologics and Biosimilars
Figure 2014 Global FOB Policy and Regulations
Table Industry News List of Biologics and Biosimilars
Figure 2014 APAC Overview of Average Monthly Labor Cost
Figure 2014 Americas Overview of Average Monthly Labor Cost
Figure 2014 EMEA Overview of Average Monthly Labor Cost
Figure 2011-2016 USA Quarterly Employment Cost Index (ECI)
Figure 2011-2016 EU Quarterly Labor Cost Index
Figure 2011-2016 Japan Yearly Manufacturing Cash Earnings and Growth Rate
Table 2014 Global Electricity Price of Resident and Industry (USD/Kw•h) by Country
Table Manufacturing Cost Structure Analysis of Biologics and Biosimilars in 2014
Figure Production Flow Chart of Mammalian Cell Expression System Producing Line
Figure Production Flow Chart of Bacterial cell expression system Producing Line
Figure Biologics and Biosimilars Marketing Process
Figure Global Gross Analysis of Biologics and Biosimilars 2011-2016
Table Revenue (M USD) and Commercial Production Date of Global Biologics and Biosimilars Key Manufacturers in 2014
Table R&D Status and Technology Source of Global Biologics and Biosimilars Key Manufacturers in 2014
Table Global of Biologics by Regions 2011-2016 (M USD)
Figure Global Sales Market Share of Biologics by Regions in 2010
Figure Global Production Market Share of Biologics by Regions in 2011
Figure Global Production Market Share of Biologics by Regions in 2012
Figure Global Production Market Share of Biologics by Regions in 2013
Figure Global Production Market Share of Biologics by Regions in 2014
Figure Global Production Market Share of Biologics by Regions in 2015
Table Global Production of Biosimilars by Regions 2011-2016 (M USD)
Figure Global Production Market Share of Biosimilars by Regions in 2010
Figure Global Production Market Share of Biosimilars by Regions in 2011
Figure Global Production Market Share of Biosimilars by Regions in 2012
Figure Global Production Market Share of Biosimilars by Regions in 2013
Figure Global Production Market Share of Biosimilars by Regions in 2014
Figure Global Production Market Share of Biosimilars by Regions in 2015
Table Global Production of Biologics and Biosimilars by Type 2011-2016 (K Units)
Figure Global Production Market Share of Biologics and Biosimilars by Type in 2014
Table Global Production of Biologics and Biosimilars by Applications 2011-2016 (M USD)
Figure Global Production Market Share of Biologics and Biosimilars by Applications in 2014
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of US 2011-2016
Table US Supply, Import, Export and Consumption of Biologics 2011-2016 (M USD)
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of US 2011-2016
Table US Supply, Import, Export and Consumption of Biosimilars 2011-2016 (M USD)
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of EU 2011-2016
Table EU Supply, Import, Export and Consumption of Biologics 2011-2016 (M USD)
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of EU 2011-2016
Table EU Supply, Import, Export and Consumption of Biosimilars 2011-2016 (M USD)
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of EU 2011-2016
Table EU Supply, Import, Export and Consumption of Biosimilars 2011-2016 (M USD)
Table China Supply, Import, Export and Consumption of Biologics 2011-2016 (M USD)
Table China Supply, Import, Export and Consumption of Biosimilars 2011-2016 (M USD)
Table Global Consumption Volume of Biologics by Regions 2011-2016 (M USD)
Figure Global Consumption Volume of Biologics by Regions in 2010 (M USD)
Figure Global Consumption Volume of Biologics by Regions in 2011 (M USD)
Figure Global Consumption Volume of Biologics by Regions in 2012 (M USD)
Figure Global Consumption Volume of Biologics by Regions in 2013 (M USD)
Figure Global Consumption Volume of Biologics by Regions in 2014 (M USD)
Figure Global Consumption Volume of Biologics by Regions in 2015 (M USD)
Table Global Consumption Value of Biosimilars by Regions 2011-2016 (M USD)
Figure Global Consumption Value of Biosimilars by Regions in 2010 (M USD)
Figure Global Consumption Value of Biosimilars by Regions in 2011 (M USD)
Figure Global Consumption Value of Biosimilars by Regions in 2012 (M USD)
Figure Global Consumption Value of Biosimilars by Regions in 2013 (M USD)
Figure Global Consumption Value of Biosimilars by Regions in 2014 (M USD)
Figure Global Consumption Value and Biosimilars by Regions in 2015 (M USD)
Table Global and Major Manufacturers Revenue of Biologics 2011-2016 (M USD)
Table Global and Major Manufacturers Revenue Market Share of Biologics 2011-2016 (M USD)
Figure Global Market Share of Major Biologics Manufacturers in 2010
Figure Global Market Share of Major Biologics Manufacturers in 2011
Figure Global Market Share of Major Biologics Manufacturers in 2012
Figure Global Market Share of Major Biologics Manufacturers in 2013
Figure Global Market Share of Major Biologics Manufacturers in 2014
Figure Global Market Share of Major Biologics Manufacturers in 2015
Table China Major Manufacturers Revenue of Major Biologics Manufacturers in 2011-2016
Table China Major Manufacturers Revenue Market Share of Major Biologics Manufacturers in 2011-2016
Figure China Revenue Market Share of Major Biologics Manufacturers in 2010
Figure China Revenue Market Share of Major Biologics Manufacturers in 2011
Figure China Revenue Market Share of Major Biologics Manufacturers in 2012
Figure China Revenue Market Share of Major Biologics Manufacturers in 2013
Figure China Revenue Market Share of Major Biologics Manufacturers in 2014
Figure China Revenue Market Share of Major Biologics Manufacturers in 2015
Table Global and Major Manufacturers Revenue of Biosimilars 2011-2016 (M USD)
Table Global and Major Manufacturers Revenue Market Share of Biosimilars 2011-2016
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2010
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2011
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2012
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2013
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2014
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2015
Table China Major Manufacturers Revenue of Major Biosimilars Manufacturers in 2011-2016
Table China Major Manufacturers Revenue Market Share of Major Biosimilars Manufacturers in 2011-2016
Figure China Revenue Market Share of Major Biosimilars Manufacturers in 2010
Figure China Revenue Market Share of Major Biosimilars Manufacturers in 2011
Figure China Revenue Market Share of Major Biosimilars Manufacturers in 2012
Figure China Revenue Market Share of Major Biosimilars Manufacturers in 2013
Figure China Revenue Market Share of Major Biosimilars Manufacturers in 2014
Figure China Revenue Market Share of Major Biosimilars Manufacturers in 2015
Figure Global Sales (M USD) and Growth Rate of Biologics and Biosimilars 2011-2016
Figure China Sales (M USD) and Growth Rate of Biologics and Biosimilars 2011-2016
Table Global Supply, Sales and Gap of Biologics 2011-2016 (M USD)
Table Global Supply, Sales and Gap of Biosimilars 2011-2016 (M USD)
Table China Supply, Sales and Gap of Biologics 2011-2016 (M USD)
Table China Supply, Sales and Gap of Biosimilars 2011-2016 (M USD)
Table China Import, Export and Consumption of Biologics 2011-2016 (M USD)
Table China Import, Export and Consumption of Biosimilars 2011-2016 (M USD)
Table Gross Margin of Global Biologics and Biosimilars Major Manufacturers 2011-2016
Figure Gross Margin of Global Biologics and Biosimilars Major Manufacturers in 2014
Table Global and Major Manufacturers Revenue of Biologics 2011-2016 (M USD)
Table Global and Major Manufacturers Revenue Market Share of Biologics 2011-2016 (M USD)
Figure Global Revenue Market Share of Major Biologics Manufacturers in 2010
Figure Global Revenue Market Share of Major Biologics Manufacturers in 2011
Figure Global Revenue Market Share of Major Biologics and Biosimilars Manufacturers in 2012
Figure Global Revenue Market Share of Major Biologics Manufacturers in 2013
Figure Global Revenue Market Share of Major Biologics Manufacturers in 2014
Figure Global Revenue Market Share of Major Biologics Manufacturers in 2015
Table China Major Manufacturers Revenue of Major Biosimilars Manufacturers in 2011-2016
Table China Major Manufacturers Revenue Market Share of Major Biosimilars Manufacturers in 2011-2016
Table Global and Major Manufacturers Revenue of Biosimilars 2011-2016 (M USD)
Table Global and Major Manufacturers Revenue Market Share of Biosimilars 2011-2016 (M USD)
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2010
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2011
Figure Global Revenue Market Share of Major Biosimilars and Biosimilars Manufacturers in 2012
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2013
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2014
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2015
Table China Major Manufacturers Revenue of Major Biosimilars Manufacturers in 2011-2016
Table China Major Manufacturers Revenue Market Share of Major Biosimilars Manufacturers in 2011-2016
Table Global Cost (M USD), Revenue (M USD) and Gross Margin of Biologics 2011-2016
Table China Cost (M USD), Revenue (M USD) and Gross Margin of Biologics 2011-2016
Table Global Cost (M USD), Revenue (M USD) and Gross Margin of Biosimilars 2011-2016
Table China Cost (M USD), Revenue (M USD) and Gross Margin of Biosimilars 2011-2016
Table Roche Company Profile
Figure Biologics and Biosimilars Picture of Roche
Table Biologics and Biosimilars Specifications of Roche
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Roche 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Roche 2011-2016
Figure Roche Biologics Revenue (M USD) and Global Market Share of 2011-2016
Table Amgen Company Profile
Figure Neulasta of Amgen
Figure Neupogen of Amgen
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Amgen 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Amgen 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of Amgen 2011-2016
Table AbbVie Profile with Contact Information, Plant Location, Capacity, Revenue
Figure Humira of AbbVie
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of AbbVie 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of AbbVie 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of AbbVie 2011-2016
Table Sanofi-Aventis Company Profile with Contact Information, Plant Location, Capacity, Revenue
Figure Insulin of Sanofi-Aventis
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Sanofi-Aventis 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Sanofi-Aventis 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of Sanofi-Aventis 2011-2016
Table Johnson & Johnson Company Profile with Contact Information, Plant Location, Capacity, Revenue.
Table Epoetin alfa of Johnson & Johnson
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Johnson & Johnson 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Johnson & Johnson 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of Johnson & Johnson 2011-2016
Table Pfizer Profile with Contact Information, Plant Location, Capacity, Revenue
Figure recombinant factor of Pfizer
Figure recombinant factor IX of Pfizer
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Pfizer 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Pfizer 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share Pfizer of 2011-2016
Table Novo Nordisk Company Profile with Contact Information, Plant Location, Capacity, Revenue
Figure Insulin of Novo Nordisk
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Novo Nordisk 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Novo Nordisk 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of Novo Nordisk 2011-2016
Table Eli Lilly Company Profile with Contact Information, Plant Location, Capacity, Revenue
Figure Insulin of Eli Lilly
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Eli Lilly 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Eli Lilly 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of Eli Lilly 2011-2016
Table Novartis Company Profile with Contact Information, Plant Location, Capacity, Revenue
Figure of atumumab of Novartis
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Novartis 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Novartis 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of Novartis 2011-2016
Table Merck Company Profile with Contact Information, Plant Location, Capacity, Revenue
Figure Insulin of Merck
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Merck 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Merck 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of Merck 2011-2016
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Sun Pharma 2011-2016
Table 3sbio Company Profile with Contact Information, Plant Location, Capacity, Revenue
Figure Biologicas and Biosimilars Picture of 3sbio
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of 3sbio 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of 3sbio 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of 3sbio 2011-2016
Table Changchun High Tech Company Profile with Contact Information, Plant Location, Capacity, Revenue.
Figure Biologicas and Biosimilars Picture of Changchun High and New Technology Industry
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Changchun High Tech 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Changchun High Tech 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of 2011-2016
Table CP Guojian Pharmacy Company Profile with Contact Information, Plant Location, Capacity, Revenue
Figure Biologicas and Biosimilars Picture of CP Guojian
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of CP Guojian 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of CP Guojian 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of CP Guojian 2011-2016
Table Biotech Pharma Company Profile with Contact Information, Plant Location, Capacity, Revenue
Figure Biologicas and Biosimilars Picture of Biotech Pharma
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Gelgen Biopharma 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Gelgen Biopharma 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of Gelgen Biopharma 2011-2016
Table Gelgen Biopharma Company Profile with Contact Information, Plant Location, Capacity, Revenue
Figure Biologicas and Biosimilars Picture of Gelgen Biopharma
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Gelgen Biopharma 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Gelgen Biopharma 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of Gelgen Biopharma 2011-2016
Table Innovent Company Profile with Contact Information, Plant Location, Capacity, Revenue, etc.
Figure Biologicas and Biosimilars Picture of Innovent
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Innovent 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Innovent 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of Innovent 2011-2016
Table Tong Hua Dong Bao Group Company Profile with Contact Information, Plant Location, Capacity, Revenue
Figure Insulin Picture of Tong Hua Dong Bao Group
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Tong Hua Dong Bao Group 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Tong Hua Dong Bao Group 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of Tong Hua Dong Bao Group 2011-2016
Table Ganlee Company Profile with Contact Information, Plant Location, Capacity, Revenue
Table Insulin Picture of Ganlee
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Ganlee 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Ganlee 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of Ganlee 2011-2016
Table United Laboratories Company Profile with Contact Information, Plant Location, Capacity, Revenue
Figure Insulin Picture of United Laboratories
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of United Laboratories 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of United Laboratories 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of United Laboratories 2011-2016
Figure Biosimilars Picture of SANDOZ
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of SANDOZ 2011-2016
Figure Biosimilars Revenue (M USD) and Growth Rate of SANDOZ 2011-2016
Table Teva Company Profile
Figure Biosimilars Picture of Teva
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Teva 2011-2016
Figure Biosimilars Revenue (M USD) and Growth Rate of Teva 2011-2016
Figure Biosimilars Revenue (M USD) and Global Market Share of Teva 2011-2016
Table Hospira Company Profile
Figure Biosimilars Picture of Hospira
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Hospira 2011-2016
Figure Biosimilars Revenue (M USD) and Growth Rate of Hospira 2011-2016
Figure Biosimilars Revenue (M USD) and Global Market Share of Hospira 2011-2016
Figure Biosimilars Picture of MYLAN
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of MYLAN 2011-2016
Figure Biosimilars Revenue (M USD) and Growth Rate of MYLAN 2011-2016
Figure Biosimilars Revenue (M USD) and Global Market Share of MYLAN 2011-2016
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Sun Pharma 2011-2016
Figure Biosimilars Revenue (M USD) and Growth Rate of Sun Pharma 2011-2016
Figure Biosimilars Revenue (M USD) and Global Market Share of Sun Pharma 2011-2016
Table 3sbio Company Profile with Contact Information, Plant Location, Capacity, Revenue
Figure Biosimilars Picture of 3sbio
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of 3sbio 2011-2016
Figure Biosimilars Revenue (M USD) and Growth Rate of 3sbio 2011-2016
Figure Biosimilars Revenue (M USD) and Global Market Share of 3sbio 2011-2016
Table Changchun High Tech Company Profile with Contact Information, Plant Location, Capacity, Revenue.
Figure Biosimilars Picture of Changchun High and New Technology Industry
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Changchun High Tech 2011-2016
Figure Biosimilars Revenue (M USD) and Growth Rate of Changchun High Tech 2011-2016
Figure Biosimilars Revenue (M USD) and Global Market Share of Changchun High Tech 2011-2016
Table CP Guojian Pharmacy Company Profile with Contact Information, Plant Location, Capacity, Revenue
Figure Biosimilars Picture of CP Guojian Pharmacy
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of CP Guojian Pharmacy 2011-2016
Figure Biosimilars Revenue (M USD) and Growth Rate of CP Guojian Pharmacy 2011-2016
Figure CP Guojian Pharmacy Biosimilars Revenue (M USD) and Global Market Share of 2011-2016
Table Biotech Pharma Company Profile with Contact Information, Plant Location, Capacity, Revenue, etc.
Figure Biosimilars Picture of Biotech Pharma
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Biotech Pharma 2011-2016
Figure Biosimilars Revenue (M USD) and Growth Rate of Biotech Pharma 2011-2016
Figure Biosimilars Revenue (M USD) and Global Market Share of Biotech Pharma 2011-2016
Table Gelgen Biopharma Company Profile with Contact Information, Plant Location, Capacity, Revenue, etc.
Figure Biosimilars Picture of Gelgen Biopharma
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Gelgen Biopharma 2011-2016
Figure Biosimilars Revenue (M USD) and Growth Rate of Gelgen Biopharma 2011-2016
Figure Biosimilars Revenue (M USD) and Global Market Share of Gelgen Biopharma 2011-2016
Figure Global Revenue Market Share of Biologics and Biosimilar by Regions in 2014
Figure Global Consumption Market Share of Biologics and Biosimilar by Regions in 2014
Table Gross Margin of Global Regions 2011-2016
Table Gross Margin of Different Biologics and Biosimilars Applications
Figure Biologics and Biosimilars Domestic Marketing Channels Status
Figure Imported Biologics and Biosimilars Marketing Channels Status
Table Regional Import, Export, and Trade of Biologics (M USD)
Table Regional Import, Export, and Trade of Biosimilars (M USD)
Figure Global Revenue (M USD) and Growth Rate of Biologics 2016-2021
Figure Global Revenue (M USD) and Growth Rate Biosimilars 2016-2021
Figure China Revenue (M USD) and Growth Rate of Biologics 2016-2021
Figure China Revenue (M USD) and Growth Rate of Biosimilars 2016-2021
Figure Global Revenue Market Share of Major Biologics and Biosimilars Manufacturers in 2016
Figure Global Revenue Market Share of Major Biologics and Biosimilars Manufacturers in 2021
Figure Revenue Market Share of China Major Biologics and Biosimilars Manufacturers in 2016
Figure Revenue Market Share of China Major Biologics and Biosimilars Manufacturers in 2021
Figure Global and China Sales (M USD) and Growth Rate of Biologics 2016-2021
Figure Global and China Sales (M USD) and Growth Rate of Biosimilars 2016-2021
Table Global Supply, Sales and Gap of Biologics 2016-2021 (M USD)
Table China Supply, Sales and Gap of Biologics 2016-2021 (M USD)
Table Global Supply, Sales and Gap of Biosimilars 2016-2021 (M USD)
Table China Supply, Sales and Gap of Biosimilars 2016-2021 (M USD)
Table China Production, Import, Export and Consumption of Biologics and Biosimilars 2016-2021 (M USD)
Table China Production, Import, Export and Consumption of Biologics and Biosimilars 2016-2021 (M USD)
Table Global Cost (M USD), Revenue (M USD) and Gross Margin of Biologics and Biosimilars 2016-2021
Table China Cost (M USD), Revenue (M USD) and Gross Margin of Biologics and Biosimilars 2016-2021
Table Global Cost (M USD), Revenue (M USD) and Gross Margin of Biologics and Biosimilars 2016-2021
Table China Cost (M USD), Revenue (M USD) and Gross Margin of Biologics and Biosimilars 2016-2021
Table Manufacturing Equipment Suppliers of Biologicas and Biosimilars with Contact Information
Table Major Suppliers of Biologicas and Biosimilars with Contact Information
Table Key Consumers of Biologicas and Biosimilars with Contact Information
Figure Supply Chain Relationship Analysis of Biologics and Biosimilars
Figure Supply Chain Relationship Analysis of Biologicas and Biosimilars
Table Biologics and Biosimilars New Project SWOT Analysis for Chinese Company
Table New Project Investment Feasibility Analysis of Biologics and Biosimilars
Figure Biologics and Biosimilars Product Picture
Figure Biologics and Biosimilars Product Picture
Table Specifications of Biologics and Biosimilars
Table Classification of Biologics and Biosimilars
Figure Global Production Market Share of Biologics and Biosimilars by Type in 2015
Table Application Fields of Biologics and Biosimilars Products
Figure 2014 Global Biologics and Biosimilars Major Applications Sales Share
Figure Industry Chain Structure of Biologics and Biosimilars
Table Industry Policy of Biologics and Biosimilars
Figure 2014 Global FOB Policy and Regulations
Table Industry News List of Biologics and Biosimilars
Figure 2014 APAC Overview of Average Monthly Labor Cost
Figure 2014 Americas Overview of Average Monthly Labor Cost
Figure 2014 EMEA Overview of Average Monthly Labor Cost
Figure 2011-2016 USA Quarterly Employment Cost Index (ECI)
Figure 2011-2016 EU Quarterly Labor Cost Index
Figure 2011-2016 Japan Yearly Manufacturing Cash Earnings and Growth Rate
Table 2014 Global Electricity Price of Resident and Industry (USD/Kw•h) by Country
Table Manufacturing Cost Structure Analysis of Biologics and Biosimilars in 2014
Figure Production Flow Chart of Mammalian Cell Expression System Producing Line
Figure Production Flow Chart of Bacterial cell expression system Producing Line
Figure Biologics and Biosimilars Marketing Process
Figure Global Gross Analysis of Biologics and Biosimilars 2011-2016
Table Revenue (M USD) and Commercial Production Date of Global Biologics and Biosimilars Key Manufacturers in 2014
Table R&D Status and Technology Source of Global Biologics and Biosimilars Key Manufacturers in 2014
Table Global of Biologics by Regions 2011-2016 (M USD)
Figure Global Sales Market Share of Biologics by Regions in 2010
Figure Global Production Market Share of Biologics by Regions in 2011
Figure Global Production Market Share of Biologics by Regions in 2012
Figure Global Production Market Share of Biologics by Regions in 2013
Figure Global Production Market Share of Biologics by Regions in 2014
Figure Global Production Market Share of Biologics by Regions in 2015
Table Global Production of Biosimilars by Regions 2011-2016 (M USD)
Figure Global Production Market Share of Biosimilars by Regions in 2010
Figure Global Production Market Share of Biosimilars by Regions in 2011
Figure Global Production Market Share of Biosimilars by Regions in 2012
Figure Global Production Market Share of Biosimilars by Regions in 2013
Figure Global Production Market Share of Biosimilars by Regions in 2014
Figure Global Production Market Share of Biosimilars by Regions in 2015
Table Global Production of Biologics and Biosimilars by Type 2011-2016 (K Units)
Figure Global Production Market Share of Biologics and Biosimilars by Type in 2014
Table Global Production of Biologics and Biosimilars by Applications 2011-2016 (M USD)
Figure Global Production Market Share of Biologics and Biosimilars by Applications in 2014
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of US 2011-2016
Table US Supply, Import, Export and Consumption of Biologics 2011-2016 (M USD)
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of US 2011-2016
Table US Supply, Import, Export and Consumption of Biosimilars 2011-2016 (M USD)
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of EU 2011-2016
Table EU Supply, Import, Export and Consumption of Biologics 2011-2016 (M USD)
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of EU 2011-2016
Table EU Supply, Import, Export and Consumption of Biosimilars 2011-2016 (M USD)
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of EU 2011-2016
Table EU Supply, Import, Export and Consumption of Biosimilars 2011-2016 (M USD)
Table China Supply, Import, Export and Consumption of Biologics 2011-2016 (M USD)
Table China Supply, Import, Export and Consumption of Biosimilars 2011-2016 (M USD)
Table Global Consumption Volume of Biologics by Regions 2011-2016 (M USD)
Figure Global Consumption Volume of Biologics by Regions in 2010 (M USD)
Figure Global Consumption Volume of Biologics by Regions in 2011 (M USD)
Figure Global Consumption Volume of Biologics by Regions in 2012 (M USD)
Figure Global Consumption Volume of Biologics by Regions in 2013 (M USD)
Figure Global Consumption Volume of Biologics by Regions in 2014 (M USD)
Figure Global Consumption Volume of Biologics by Regions in 2015 (M USD)
Table Global Consumption Value of Biosimilars by Regions 2011-2016 (M USD)
Figure Global Consumption Value of Biosimilars by Regions in 2010 (M USD)
Figure Global Consumption Value of Biosimilars by Regions in 2011 (M USD)
Figure Global Consumption Value of Biosimilars by Regions in 2012 (M USD)
Figure Global Consumption Value of Biosimilars by Regions in 2013 (M USD)
Figure Global Consumption Value of Biosimilars by Regions in 2014 (M USD)
Figure Global Consumption Value and Biosimilars by Regions in 2015 (M USD)
Table Global and Major Manufacturers Revenue of Biologics 2011-2016 (M USD)
Table Global and Major Manufacturers Revenue Market Share of Biologics 2011-2016 (M USD)
Figure Global Market Share of Major Biologics Manufacturers in 2010
Figure Global Market Share of Major Biologics Manufacturers in 2011
Figure Global Market Share of Major Biologics Manufacturers in 2012
Figure Global Market Share of Major Biologics Manufacturers in 2013
Figure Global Market Share of Major Biologics Manufacturers in 2014
Figure Global Market Share of Major Biologics Manufacturers in 2015
Table China Major Manufacturers Revenue of Major Biologics Manufacturers in 2011-2016
Table China Major Manufacturers Revenue Market Share of Major Biologics Manufacturers in 2011-2016
Figure China Revenue Market Share of Major Biologics Manufacturers in 2010
Figure China Revenue Market Share of Major Biologics Manufacturers in 2011
Figure China Revenue Market Share of Major Biologics Manufacturers in 2012
Figure China Revenue Market Share of Major Biologics Manufacturers in 2013
Figure China Revenue Market Share of Major Biologics Manufacturers in 2014
Figure China Revenue Market Share of Major Biologics Manufacturers in 2015
Table Global and Major Manufacturers Revenue of Biosimilars 2011-2016 (M USD)
Table Global and Major Manufacturers Revenue Market Share of Biosimilars 2011-2016
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2010
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2011
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2012
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2013
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2014
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2015
Table China Major Manufacturers Revenue of Major Biosimilars Manufacturers in 2011-2016
Table China Major Manufacturers Revenue Market Share of Major Biosimilars Manufacturers in 2011-2016
Figure China Revenue Market Share of Major Biosimilars Manufacturers in 2010
Figure China Revenue Market Share of Major Biosimilars Manufacturers in 2011
Figure China Revenue Market Share of Major Biosimilars Manufacturers in 2012
Figure China Revenue Market Share of Major Biosimilars Manufacturers in 2013
Figure China Revenue Market Share of Major Biosimilars Manufacturers in 2014
Figure China Revenue Market Share of Major Biosimilars Manufacturers in 2015
Figure Global Sales (M USD) and Growth Rate of Biologics and Biosimilars 2011-2016
Figure China Sales (M USD) and Growth Rate of Biologics and Biosimilars 2011-2016
Table Global Supply, Sales and Gap of Biologics 2011-2016 (M USD)
Table Global Supply, Sales and Gap of Biosimilars 2011-2016 (M USD)
Table China Supply, Sales and Gap of Biologics 2011-2016 (M USD)
Table China Supply, Sales and Gap of Biosimilars 2011-2016 (M USD)
Table China Import, Export and Consumption of Biologics 2011-2016 (M USD)
Table China Import, Export and Consumption of Biosimilars 2011-2016 (M USD)
Table Gross Margin of Global Biologics and Biosimilars Major Manufacturers 2011-2016
Figure Gross Margin of Global Biologics and Biosimilars Major Manufacturers in 2014
Table Global and Major Manufacturers Revenue of Biologics 2011-2016 (M USD)
Table Global and Major Manufacturers Revenue Market Share of Biologics 2011-2016 (M USD)
Figure Global Revenue Market Share of Major Biologics Manufacturers in 2010
Figure Global Revenue Market Share of Major Biologics Manufacturers in 2011
Figure Global Revenue Market Share of Major Biologics and Biosimilars Manufacturers in 2012
Figure Global Revenue Market Share of Major Biologics Manufacturers in 2013
Figure Global Revenue Market Share of Major Biologics Manufacturers in 2014
Figure Global Revenue Market Share of Major Biologics Manufacturers in 2015
Table China Major Manufacturers Revenue of Major Biosimilars Manufacturers in 2011-2016
Table China Major Manufacturers Revenue Market Share of Major Biosimilars Manufacturers in 2011-2016
Table Global and Major Manufacturers Revenue of Biosimilars 2011-2016 (M USD)
Table Global and Major Manufacturers Revenue Market Share of Biosimilars 2011-2016 (M USD)
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2010
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2011
Figure Global Revenue Market Share of Major Biosimilars and Biosimilars Manufacturers in 2012
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2013
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2014
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2015
Table China Major Manufacturers Revenue of Major Biosimilars Manufacturers in 2011-2016
Table China Major Manufacturers Revenue Market Share of Major Biosimilars Manufacturers in 2011-2016
Table Global Cost (M USD), Revenue (M USD) and Gross Margin of Biologics 2011-2016
Table China Cost (M USD), Revenue (M USD) and Gross Margin of Biologics 2011-2016
Table Global Cost (M USD), Revenue (M USD) and Gross Margin of Biosimilars 2011-2016
Table China Cost (M USD), Revenue (M USD) and Gross Margin of Biosimilars 2011-2016
Table Roche Company Profile
Figure Biologics and Biosimilars Picture of Roche
Table Biologics and Biosimilars Specifications of Roche
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Roche 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Roche 2011-2016
Figure Roche Biologics Revenue (M USD) and Global Market Share of 2011-2016
Table Amgen Company Profile
Figure Neulasta of Amgen
Figure Neupogen of Amgen
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Amgen 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Amgen 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of Amgen 2011-2016
Table AbbVie Profile with Contact Information, Plant Location, Capacity, Revenue
Figure Humira of AbbVie
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of AbbVie 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of AbbVie 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of AbbVie 2011-2016
Table Sanofi-Aventis Company Profile with Contact Information, Plant Location, Capacity, Revenue
Figure Insulin of Sanofi-Aventis
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Sanofi-Aventis 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Sanofi-Aventis 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of Sanofi-Aventis 2011-2016
Table Johnson & Johnson Company Profile with Contact Information, Plant Location, Capacity, Revenue.
Table Epoetin alfa of Johnson & Johnson
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Johnson & Johnson 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Johnson & Johnson 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of Johnson & Johnson 2011-2016
Table Pfizer Profile with Contact Information, Plant Location, Capacity, Revenue
Figure recombinant factor of Pfizer
Figure recombinant factor IX of Pfizer
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Pfizer 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Pfizer 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share Pfizer of 2011-2016
Table Novo Nordisk Company Profile with Contact Information, Plant Location, Capacity, Revenue
Figure Insulin of Novo Nordisk
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Novo Nordisk 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Novo Nordisk 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of Novo Nordisk 2011-2016
Table Eli Lilly Company Profile with Contact Information, Plant Location, Capacity, Revenue
Figure Insulin of Eli Lilly
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Eli Lilly 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Eli Lilly 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of Eli Lilly 2011-2016
Table Novartis Company Profile with Contact Information, Plant Location, Capacity, Revenue
Figure of atumumab of Novartis
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Novartis 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Novartis 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of Novartis 2011-2016
Table Merck Company Profile with Contact Information, Plant Location, Capacity, Revenue
Figure Insulin of Merck
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Merck 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Merck 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of Merck 2011-2016
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Sun Pharma 2011-2016
Table 3sbio Company Profile with Contact Information, Plant Location, Capacity, Revenue
Figure Biologicas and Biosimilars Picture of 3sbio
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of 3sbio 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of 3sbio 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of 3sbio 2011-2016
Table Changchun High Tech Company Profile with Contact Information, Plant Location, Capacity, Revenue.
Figure Biologicas and Biosimilars Picture of Changchun High and New Technology Industry
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Changchun High Tech 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Changchun High Tech 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of 2011-2016
Table CP Guojian Pharmacy Company Profile with Contact Information, Plant Location, Capacity, Revenue
Figure Biologicas and Biosimilars Picture of CP Guojian
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of CP Guojian 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of CP Guojian 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of CP Guojian 2011-2016
Table Biotech Pharma Company Profile with Contact Information, Plant Location, Capacity, Revenue
Figure Biologicas and Biosimilars Picture of Biotech Pharma
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Gelgen Biopharma 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Gelgen Biopharma 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of Gelgen Biopharma 2011-2016
Table Gelgen Biopharma Company Profile with Contact Information, Plant Location, Capacity, Revenue
Figure Biologicas and Biosimilars Picture of Gelgen Biopharma
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Gelgen Biopharma 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Gelgen Biopharma 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of Gelgen Biopharma 2011-2016
Table Innovent Company Profile with Contact Information, Plant Location, Capacity, Revenue, etc.
Figure Biologicas and Biosimilars Picture of Innovent
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Innovent 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Innovent 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of Innovent 2011-2016
Table Tong Hua Dong Bao Group Company Profile with Contact Information, Plant Location, Capacity, Revenue
Figure Insulin Picture of Tong Hua Dong Bao Group
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Tong Hua Dong Bao Group 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Tong Hua Dong Bao Group 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of Tong Hua Dong Bao Group 2011-2016
Table Ganlee Company Profile with Contact Information, Plant Location, Capacity, Revenue
Table Insulin Picture of Ganlee
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Ganlee 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of Ganlee 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of Ganlee 2011-2016
Table United Laboratories Company Profile with Contact Information, Plant Location, Capacity, Revenue
Figure Insulin Picture of United Laboratories
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of United Laboratories 2011-2016
Figure Biologics Revenue (M USD) and Growth Rate of United Laboratories 2011-2016
Figure Biologics Revenue (M USD) and Global Market Share of United Laboratories 2011-2016
Figure Biosimilars Picture of SANDOZ
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of SANDOZ 2011-2016
Figure Biosimilars Revenue (M USD) and Growth Rate of SANDOZ 2011-2016
Table Teva Company Profile
Figure Biosimilars Picture of Teva
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Teva 2011-2016
Figure Biosimilars Revenue (M USD) and Growth Rate of Teva 2011-2016
Figure Biosimilars Revenue (M USD) and Global Market Share of Teva 2011-2016
Table Hospira Company Profile
Figure Biosimilars Picture of Hospira
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Hospira 2011-2016
Figure Biosimilars Revenue (M USD) and Growth Rate of Hospira 2011-2016
Figure Biosimilars Revenue (M USD) and Global Market Share of Hospira 2011-2016
Figure Biosimilars Picture of MYLAN
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of MYLAN 2011-2016
Figure Biosimilars Revenue (M USD) and Growth Rate of MYLAN 2011-2016
Figure Biosimilars Revenue (M USD) and Global Market Share of MYLAN 2011-2016
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Sun Pharma 2011-2016
Figure Biosimilars Revenue (M USD) and Growth Rate of Sun Pharma 2011-2016
Figure Biosimilars Revenue (M USD) and Global Market Share of Sun Pharma 2011-2016
Table 3sbio Company Profile with Contact Information, Plant Location, Capacity, Revenue
Figure Biosimilars Picture of 3sbio
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of 3sbio 2011-2016
Figure Biosimilars Revenue (M USD) and Growth Rate of 3sbio 2011-2016
Figure Biosimilars Revenue (M USD) and Global Market Share of 3sbio 2011-2016
Table Changchun High Tech Company Profile with Contact Information, Plant Location, Capacity, Revenue.
Figure Biosimilars Picture of Changchun High and New Technology Industry
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Changchun High Tech 2011-2016
Figure Biosimilars Revenue (M USD) and Growth Rate of Changchun High Tech 2011-2016
Figure Biosimilars Revenue (M USD) and Global Market Share of Changchun High Tech 2011-2016
Table CP Guojian Pharmacy Company Profile with Contact Information, Plant Location, Capacity, Revenue
Figure Biosimilars Picture of CP Guojian Pharmacy
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of CP Guojian Pharmacy 2011-2016
Figure Biosimilars Revenue (M USD) and Growth Rate of CP Guojian Pharmacy 2011-2016
Figure CP Guojian Pharmacy Biosimilars Revenue (M USD) and Global Market Share of 2011-2016
Table Biotech Pharma Company Profile with Contact Information, Plant Location, Capacity, Revenue, etc.
Figure Biosimilars Picture of Biotech Pharma
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Biotech Pharma 2011-2016
Figure Biosimilars Revenue (M USD) and Growth Rate of Biotech Pharma 2011-2016
Figure Biosimilars Revenue (M USD) and Global Market Share of Biotech Pharma 2011-2016
Table Gelgen Biopharma Company Profile with Contact Information, Plant Location, Capacity, Revenue, etc.
Figure Biosimilars Picture of Gelgen Biopharma
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Gelgen Biopharma 2011-2016
Figure Biosimilars Revenue (M USD) and Growth Rate of Gelgen Biopharma 2011-2016
Figure Biosimilars Revenue (M USD) and Global Market Share of Gelgen Biopharma 2011-2016
Figure Global Revenue Market Share of Biologics and Biosimilar by Regions in 2014
Figure Global Consumption Market Share of Biologics and Biosimilar by Regions in 2014
Table Gross Margin of Global Regions 2011-2016
Table Gross Margin of Different Biologics and Biosimilars Applications
Figure Biologics and Biosimilars Domestic Marketing Channels Status
Figure Imported Biologics and Biosimilars Marketing Channels Status
Table Regional Import, Export, and Trade of Biologics (M USD)
Table Regional Import, Export, and Trade of Biosimilars (M USD)
Figure Global Revenue (M USD) and Growth Rate of Biologics 2016-2021
Figure Global Revenue (M USD) and Growth Rate Biosimilars 2016-2021
Figure China Revenue (M USD) and Growth Rate of Biologics 2016-2021
Figure China Revenue (M USD) and Growth Rate of Biosimilars 2016-2021
Figure Global Revenue Market Share of Major Biologics and Biosimilars Manufacturers in 2016
Figure Global Revenue Market Share of Major Biologics and Biosimilars Manufacturers in 2021
Figure Revenue Market Share of China Major Biologics and Biosimilars Manufacturers in 2016
Figure Revenue Market Share of China Major Biologics and Biosimilars Manufacturers in 2021
Figure Global and China Sales (M USD) and Growth Rate of Biologics 2016-2021
Figure Global and China Sales (M USD) and Growth Rate of Biosimilars 2016-2021
Table Global Supply, Sales and Gap of Biologics 2016-2021 (M USD)
Table China Supply, Sales and Gap of Biologics 2016-2021 (M USD)
Table Global Supply, Sales and Gap of Biosimilars 2016-2021 (M USD)
Table China Supply, Sales and Gap of Biosimilars 2016-2021 (M USD)
Table China Production, Import, Export and Consumption of Biologics and Biosimilars 2016-2021 (M USD)
Table China Production, Import, Export and Consumption of Biologics and Biosimilars 2016-2021 (M USD)
Table Global Cost (M USD), Revenue (M USD) and Gross Margin of Biologics and Biosimilars 2016-2021
Table China Cost (M USD), Revenue (M USD) and Gross Margin of Biologics and Biosimilars 2016-2021
Table Global Cost (M USD), Revenue (M USD) and Gross Margin of Biologics and Biosimilars 2016-2021
Table China Cost (M USD), Revenue (M USD) and Gross Margin of Biologics and Biosimilars 2016-2021
Table Manufacturing Equipment Suppliers of Biologicas and Biosimilars with Contact Information
Table Major Suppliers of Biologicas and Biosimilars with Contact Information
Table Key Consumers of Biologicas and Biosimilars with Contact Information
Figure Supply Chain Relationship Analysis of Biologics and Biosimilars
Figure Supply Chain Relationship Analysis of Biologicas and Biosimilars
Table Biologics and Biosimilars New Project SWOT Analysis for Chinese Company
Table New Project Investment Feasibility Analysis of Biologics and Biosimilars
